Literature DB >> 19172419

Fetal hemodynamic changes following maternal betamethasone administration in pregnancies with fetal growth restriction and absent end-diastolic flow in the umbilical artery.

Alexandre M Nozaki1, Rossana P V Francisco, Eduardo S V B Fonseca, Seizo Miyadahira, Marcelo Zugaib.   

Abstract

OBJECTIVES: To examine the effects of betamethasone administration on umbilical artery (UA), middle cerebral artery (MCA) and ductus venosus (DV) Doppler flow.
DESIGN: Longitudinal prospective study.
SETTING: Fetal Surveillance Unit, Department of Obstetrics and Gynecology, University of São Paulo, São Paulo, Brazil. POPULATION: Thirty-two singleton pregnancies complicated by fetal growth restriction with absent end-diastolic flow in the UA.
METHODS: Pulsatility index (PI) of the UA, MCA and DV was measured from 26 to 34 weeks prior to and within 24 or 48 hours after starting betamethasone treatment course. Analysis of variance for repeated measures was used to determine the changes in the fetal hemodynamic Doppler flow following maternal corticosteroid administration. MAIN OUTCOME MEASURES: Improvement of UA-PI within 24 hours and DV-PIV (venous pulsatility) within 48 hours from the first betamethasone dose.
RESULTS: Mean gestational age at delivery was 29.3 (+/-1.8) weeks and birthweight was 806.6 (+/-228.2) g. A reduction in the UA-PI was observed in 29 (90.6%) cases, with return of end-diastolic flow in 22 (68.7%). The mean UA-PI were 2.84 (+/-0.52) before corticosteroid administration, 2.07 (+/-0.56) within 24 hours and 2.42 (+/-0.75) after 48 hours, with a significant difference along the evaluations (p<0.001). No significant changes in the MCA Doppler were observed. DV-PIV decreased from 1.06 (+/-0.23) prior corticosteroids administration to 0.73 (+/-0.16) within 24 hours and 0.70 (+/-0.19) after 48 hours (p<0.001).
CONCLUSIONS: There was reduction in the umbilical artery and in the DV pulsatility indices within 24 hours from betamethasone administration that was maintained up to 48 hours.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19172419     DOI: 10.1080/00016340902730334

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN: 0001-6349            Impact factor:   3.636


  5 in total

1.  The short term fetal cardiovascular effects of corticosteroids used in obstetrics.

Authors:  Amanda Henry; Antonia Shand; Alec Welsh
Journal:  Australas J Ultrasound Med       Date:  2015-12-31

2.  The impact of betamethasone on fetal pulmonary, umbilical and middle cerebral artery Doppler velocimetry and its relationship with neonatal respiratory distress syndrome.

Authors:  Homeira Vafaei; Fahimeh Kaveh Baghbahadorani; Nasrin Asadi; Maryam Kasraeian; Azam Faraji; Shohreh Roozmeh; Marjan Zare; Khadije Bazrafshan
Journal:  BMC Pregnancy Childbirth       Date:  2021-03-06       Impact factor: 3.007

3.  Intrauterine Growth Restriction. Guideline of the German Society of Gynecology and Obstetrics (S2k-Level, AWMF Registry No. 015/080, October 2016).

Authors:  Sven Kehl; Jörg Dötsch; Kurt Hecher; Dietmar Schlembach; Dagmar Schmitz; Holger Stepan; Ulrich Gembruch
Journal:  Geburtshilfe Frauenheilkd       Date:  2017-11-27       Impact factor: 2.915

4.  Antenatal dexamethasone effect on Doppler blood flow velocity in women at risk for preterm birth: prospective case series.

Authors:  Elsnosy Elwany; Shaaban Omar; Abbas Ahmed; Gaber Heba; Darwish Atef
Journal:  Afr Health Sci       Date:  2018-09       Impact factor: 0.927

5.  Short-Term Effects of Dexamethasone versus Betamethasone on Ultrasonic Measures of Fetal Well-Being: Cohort from a Blinded, Randomized Trial.

Authors:  Amanda Henry; Aditi Mahajan; Caroline A Crowther; Anne Lainchbury; Lynne Roberts; Antonia W Shand; Alec W Welsh
Journal:  Fetal Diagn Ther       Date:  2021-07-28       Impact factor: 2.587

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.